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Abstract Cholesterol is a prominent modulator of the
integrity and functional activity of physiological mem-
branes and the most abundant sterol in the mammalian brain.
DHCR24-knock-out mice lack cholesterol and accumulate
desmosterol with age. Here we demonstrate that brain
cholesterol deficiency in 3-week-old DHCR24-/- mice was
associated with altered membrane composition including
disrupted detergent-resistant membrane domain (DRM)
structure. Furthermore, membrane-related functions dif-
fered extensively in the brains of these mice, resulting in
lower plasmin activity, decreased b-secretase activity and
diminished Ab generation. Age-dependent accumulation
and integration of desmosterol in brain membranes of
16-week-old DHCR24-/- mice led to the formation of
desmosterol-containing DRMs and rescued the observed
membrane-related functional deficits. Our data provide
evidence that an alternate sterol, desmosterol, can facilitate
processes that are normally cholesterol-dependent including
formation of DRMs from mouse brain extracts, membrane
receptor ligand binding and activation, and regulation of
membrane protein proteolytic activity. These data indicate
that desmosterol can replace cholesterol in membrane-
related functions in the DHCR24-/- mouse.
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Introduction
Cholesterol plays a key role in regulating the fluidity of
mammalian cell membranes and functions in a variety of
cellular processes including molecular sorting and signal-
ing, as well as protein synthesis, maturation, activity and
degradation [1–3]. Many pathological conditions, including
Alzheimer’s disease (AD), are associated with abnormali-
ties of cholesterol-related functions [4, 5]. Cholesterol
biosynthesis follows two intersecting routes: the Bloch
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synthesis pathway with desmosterol as the immediate
precursor of cholesterol and the Kandutsch–Russell path-
way with 7-dehydrocholesterol as the direct precursor [6].
The 3b-hydroxysterol-D24 reductase (DHCR24/seladin-1)
is crucial for cholesterol biosynthesis, because it is the
mediating enzyme between the two pathways, reducing the
C24 double bonds of Bloch-pathway precursors, finally
leading to formation of cholesterol. Mutations in the
dhcr24 gene resulting in the limited ability to convert
desmosterol to cholesterol, lead to a human metabolic
disorder, desmosterolosis. This rare malformation syn-
drome is characterized by severe developmental defects
and cognitive impairment. In contrast, mice with a targeted
disruption in the dhcr24 gene (DHCR24-/- mice) have an
unexpectedly mild phenotype, being small and infertile but
viable. These mice are essentially cholesterol-free, and
desmosterol was shown to account for 99% of all sterols
[7–9], raising the question whether desmosterol can func-
tionally replace cholesterol in vivo.
Cholesterol is required for the structural integrity of
lipid raft microdomains [10]. Membrane rafts are small
(10–200 nm), heterogeneous, highly dynamic, sterol- and
sphingolipid-rich domains that compartmentalize cellular
processes and that can be stabilized to form larger plat-
forms through protein–protein and protein–lipid
interactions [11]. Up to date, there is no biochemical
method for isolation of lipid rafts. However, since lipid
rafts are assumed to exist in liquid-ordered state, and since
lipid membranes in an ordered state exhibit higher resis-
tance to solubilization with non-ionic detergents than
disorder membranes [12], the composition of cellular rafts
will, to some degree, be reflected by the composition of the
so-called detergent-resistant membranes, or DRMs. DRMs
are prepared by solubilization of cell membranes in Triton
X-100 at 4C followed by separation of the soluble and
insoluble material on a density gradient. The DRM fraction
is the lipid-rich, but insoluble fraction of cell membranes,
obtained as the floating fraction.
Membrane active sterols are important for regulation of
membrane fluidity and in addition, some sterols are
responsible for promoting liquid-ordered phase formation.
Under physiological conditions, cholesterol is the only
sterol extensively available in mammalian membranes and
as such is an indispensable component of the membrane
and of lipid rafts.
Nevertheless, in addition to cholesterol, several other
sterols including lathosterol and desmosterol are mem-
brane-active sterols, defined as sterols that decrease
membrane permeability and increase the order in the lipid
acyl chains near the terminal methyl group, among other
factors [13, 14]. Lathosterol, a more distant precursor of
cholesterol, associates with rafts at least as efficiently as
cholesterol [15, 16]. Desmosterol has similar effects on
membrane lipid order, phase separation and lipid packing
in model membranes as compared to cholesterol [17, 18].
Moreover, it was shown that desmosterol could substitute
for cholesterol in maintaining cell growth, membrane
integrity and preserving caveolar invaginations in vitro
[19]. Therefore, desmosterol appears to be a candidate for a
sterol capable of substituting cholesterol in membrane-
related functions in vivo.
Generation of the amyloid-b (Ab) peptide is a mem-
brane-related event involving the transmembrane substrate
APP that is metabolized by integral membrane proteases,
the b-secretase (BACE) cleaving at the N terminus, and the
c-secretase complex cleaving within the transmembrane
domain at the C terminus of Ab [20]. Rafts contribute to
the segregation of APP from BACE [7, 21]. While
endogenous APP and a-secretases were predominantly
found in membrane compartments not associated with lipid
rafts, BACE and the c-secretase complex were shown to
reside within rafts of late Golgi and early endosomes [22–
24]. Hence, access of a- and b-secretase to APP and Ab
generation are likely determined by dynamic interactions
of APP and its secretases with lipid rafts. Reduction of
cholesterol up to 30% cause raft disorganization, leading to
increased b-cleavage and higher Ab production [7, 25].
Therefore, rafts may separate APP from the c-secretase
complex and BACE under physiological conditions, and
disruption of rafts through cholesterol depletion could
impair the sequestration of c-secretase and BACE from
APP resulting in higher rates of APP cleavage by these
secretases [7, 25, 26]. These data suggest that proper raft
organization is required to maintain the steady state levels
of Ab. Importantly, further depletion of cholesterol to a
degree [30% results in elevated levels of sAPPa, reduced
b-cleavage and diminished Ab production [21, 27–30]. In
these studies, cholesterol-lowering drugs and/or choles-
terol-extracting agents were used to reduce cellular and
membrane cholesterol levels, a procedure that is likely to
affect the functional integrity of involved secretases.
In the present work, we determined the effects of
DHCR24 deficiency on brain sterol metabolism and we
analyzed the distribution of Bloch and Kandutsch–Russel
sterols in brains of 3- and 16-week-old DHCR24-/- mice.
Knock-out mice of both age-groups were largely devoid of
brain cholesterol, while desmosterol accounted for *50%
of the lacking cholesterol concentrations in 3-week-old
DHCR24-/- mice. In 16-week-old mice, a complete sub-
stitution of cholesterol by desmosterol was determined,
with equimolar concentrations of desmosterol in knock-out
brains compared to cholesterol levels in wild type (wt)
mice.
In order to evaluate the consequences of a chronic
cholesterol deficiency on membrane organization we ana-
lyzed protein and lipid composition of DRMs in brains of
1168 Neurochem Res (2009) 34:1167–1182
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3- and 16-week-old DHCR24-/- mice. To assess the
functional relevance of cholesterol paucity, we studied
plasmin activation and APP processing as two examples of
membrane-dependent proteolyses. In brains of 3-week-old
DHCR24-/- mice, membrane composition differed con-
siderably from that of wt controls, as indicated by a major
disruption of DRMs. Moreover, membrane-related prote-
olytic functions were substantially altered as indicated by
reduced plasmin activity, lower b-secretase activity and
diminished Ab generation. In contrast, age-related des-
mosterol accumulation and integration in membranes of
16-week-old DHCR24-/- mice led to the formation of
desmosterol containing DRMs, recruitment of raft-specific
proteins in DRM compartments, restoration of secretase
activity and therefore physiological Ab generation. Fur-
thermore, desmosterol stimulated proteolytic activity of
BACE reconstituted in proteoliposomes to a comparable
extent as cholesterol.
These data show that desmosterol—when it is present in
the DHCR24-/- mouse brain as abundantly as naturally
occurring cholesterol—integrated into membranes and
facilitated formation of desmosterol-dependent DRMs that
contain specific membrane proteins, which normally
associate with cholesterol-containing DRMs. Our data
further show that an age-dependent increase in desmosterol
in DHCR24-/- mice restored proteolytic activity of BACE
in the absence of cholesterol and efficiently replaced
cholesterol in membrane-associated processes that are
normally cholesterol dependent.
Experimental Procedures
Mice
A heterozygous breeding pair with target depletion of one
DHCR24 allele was received from Dr. E. Feinstein (Quark
Biotech Inc.). Mice were bred and genotyped as described
[9]. All animal experiments and husbandry were performed
compliant with national guidelines and were approved by
the veterinarian authorities of the Canton of Zurich.
Histology
Mice were perfused transcardially under deep anesthesia
(ketamin 100 mg, xylazine 5 mg/kg bodyweight, i.p.)
using a peristaltic pump. Perfusion was performed initially
with chilled PBS pH 7.4 for 10–15 min, followed by per-
fusion with 4% PFA. Brains were removed and immersion-
fixed in 4% PFA overnight at 4C. After extensive washing
with PBS, the fixed tissue fragments were dehydrated
through a graded series of ethanol solutions followed by
xylene incubation and embedded in paraffin before cutting
histological sections of the cortex. Specimens (5 lm) were
washed in xylene, rehydrated and stained with hematox-
ylin and eosin (H/E) or Luxol fast blue according to
standard protocols. Apoptotic cells were detected per-
forming immunohistochemistry with an antibody against
cleaved caspase-3 Asp 175 (cell signaling) following the
manufacturer’s instructions. Terminal deoxynucleotidyl
transferase mediated dUTP nick end labeling assay
(TUNEL, purchased from Roche) was performed accord-
ing to the manufacturer’s protocol.
Tissue Preparation
Mouse brains (n = 5 per group) were homogenized in a
Tris-Buffer containing 2% SDS with complete protease
inhibitors (Roche) in a dounce homogenizer for 5 min on
ice. The samples were centrifuged at 100,000g for 1 h at
8C to pellet the insoluble debris. The supernatant was
considered as total homogenate and used for Western blot
analyses. Protein concentration was quantified using the
DC protein assay (BIORAD). Detergent extraction and
DRM isolation were performed as described [7]. In brief,
mouse brains (n = 3–4 per group) were homogenized in
9% sucrose in PBS containing protease inhibitors in a
dounce homogenizer using 10 strokes and 10 passages
through a 22-gauge syringe on ice. The samples were
centrifuged at 700g for 10 min to pellet the debris and the
supernatant was considered as total brain extracts. 300–
400 lg protein of brain extracts were incubated for 1 h at
4C in 1% Triton X-100, 25 mM MES pH 7.0, 5 mM
DTT, 2 mM EDTA and protease inhibitors. The extracts
were mixed with 90% sucrose prepared in MBS buffer
(25 mM MES, pH 7.0, 150 mM NaCl and protease inhib-
itors) over layered with a step gradient of 35 and 5%
sucrose in MBS. After centrifugation at 100,000g for 18 h
at 4C, fractions 4–6 were identified as the DRM fraction
by the presence of the DRM markers flotillin-1 and Prpc in
the control samples.
Primary Neuronal Cultures
Primary cultures of cortical neurons from DHCR24-/- and
wt mice were prepared from embryos as described [31].
Neurons (glial contamination \5%) were cultured in cho-
lesterol-free Neurobasal-Medium supplemented with B27
(Invitrogen). For detection of Ab in supernatants of pri-
mary neurons medium was changed 24 h before harvest.
Medium was removed from primary neurons that were
cultured for 4 or 8–10 days. 150 ll of the supernatant was
then used for ELISA without further processing. For sterol
measurements, neurons cultivated for 4, 6 and 8–10 div
were washed and scraped in PBS. Total sterols were
extracted and measured as described below. Cell viability
Neurochem Res (2009) 34:1167–1182 1169
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of primary neurons was determined using the MTT and the
LDH assay (both from Sigma) according to the manufac-
turer’s instructions.
For immunohistochemistry, neurons were fixed with 4%
PFA for 10 min at room temperature, blocked and per-
meabilized with 5% horse serum containing 0.1% Triton
X-100 for 2 h. Anti-Map2 antibody and anti GFAP anti-
body (both from Sigma) were used to determine the
percentage of neurons and astrocytes according to the
manufacturer’s instructions. In addition, Map-2 staining
was used to check cell morphology and viability of wt and
DHCR24-/- neurons. Species specific fluorescence-
labeled secondary antibodies (Amersham) were diluted in
blocking buffer and cells were stained for 2–4 h in the
dark. For analysis, cells were washed in PBS and embed-
ded in Moviol (Merk).
Choleratoxin b Subunit Binding and Internalization
Assay
For all experiments using Choleratoxin b subunit, primary
neurons were cultured in 8-well coverglass chambers
(Labtek) previously coated with polyornithin/laminin
(Sigma) in sterol-free medium for 6–8 days. For plasma
membrane binding experiments, 200 ll of culture media
containing FITC-labeled Choleratoxin-b (Sigma) at a
concentration of 1 lg/ml was added for 2 min at room
temperature. Neurons were washed twice with culture
media and directly visualized. For internalization experi-
ments, neurons were incubated in culture media containing
FITC-labeled Choleratoxin-b (Sigma) at a concentration of
1 lg/ml for 2 min at room temperature. Neurons were
washed twice with culture media, and cultured for 30 min
at 37C in a CO2 incubator (5% v/v). The culture chamber
with live cells was immediately transferred to the micro-
scope stage for direct visualization. At the microscope, the
cell culture media was exchanged twice with a 200 ll
solution of culture media pre-buffered to exactly pH 7.00
with 40 mM HEPES buffer, and images were acquired
within the next 10 min (data not shown). Next, in the same
culture chamber, the neutral solution was exchanged twice
with media pre-buffered to exactly pH 4.50 with 20 mM
citrate buffer and images were acquired within the next
10 min. FITC is an acid sensitive dye. The emission
spectrum shifts toward shorter wavelengths which are not
efficiently captured with standard FITC emission filters
(\10% emission captured at pH 4.50 with filter LP505).
Thus a ‘‘quenching’’ effect is observed in which only the
fluorescence of intracellular dye protected from the low pH
extracellular media is efficiently acquired. Plasma mem-
brane integrity is maintained for greater than 20 min at low
pH. All images were acquired with an inverted Zeiss LSM
510 meta (639 objective, N.A. 1.4, LP505 emission filter)
under identical acquisition conditions for each experiment.
The yielded results were found to be independent of the
pinhole settings. Micrographs were exported to ImageJ
(NIH) and processed for presentation using Photoshop
(Adobe). Confocal images were acquired such that the
Z-dimension was 1 micron.
Plasminogen Binding and Plasmin Activity
Brain extracts (n = 2–4 per group) were centrifuged at
100,000g and pellets were considered as membrane frac-
tions. Plasmin activity was measured as described before
[7]. In brief, pellets were resuspended in Hank’s balanced
saline solution containing 0.1% ovalbumin (Sigma) and
placed in a 96-multiwell plate in the presence of 2 mM
chromogenic substrate S-2251 (Chromogenix) to measure
endogenous plasmin activity. Absorbance was measured at
37C and 405 nm in an ultramicroplate reader every 5 min.
Antibodies, Quantification and ELISA
Monoclonal anti-flotillin-1 (clone 18, Transduction Labo-
ratories), monoclonal anti-cellular prion protein (Prpc)
POM-1 (kindly provided by Dr. A. Aguzzi, University of
Zurich), monoclonal anti-transferrin receptor (TfR) (Clone
CD-71, Santa Cruz Biotechnology Inc.), polyclonal anti-
C-terminal APP (Sigma), monoclonal anti-N-terminal APP
(22C11, Chemicon) and polyclonal anti plasminogen
(Biogenesis) were used for Western blot analysis. Mono-
clonal anti-b-actin (Abcam) and anti-GAPDH (Biodesign)
were used as internal loading controls and for normaliza-
tion of densitometric analysis of the immunoreactive
bands. SDS–PAGE and Western blotting was performed as
described [7]. Quantification of immunoreactive bands was
carried out by densitometry of the scanned films under
conditions of non-saturated signal using the ImageJ soft-
ware. Murine Ab ELISA was performed as described
[7, 32]. In brief, total brain extracts (n = 4 each) and
supernatants of primary neurons (n = 4 for each genotype
and time point) were analyzed by a modified sandwich
ELISA that detects specifically either Ab40 (HPR-conju-
gated BA27) or Ab42 (HPR-conjugated BC05) (Takeda,
Japan) according to the provider’s protocol. Ab was cap-
tured with a specific anti-Ab antibody (BNT77).
Lipid and Sterol Analysis
Lipids were extracted from membrane pellets and from
each sucrose gradient fraction according to the Bligh–Dyer
method using chloroform/methanol (n = 3–4 per group)
[33]. Sphingomyelin, the ganglioside GM1 and phospho-
lipids were determined as described [7]. Briefly,
sphingomyelin (SM) was analyzed by thin-layer
1170 Neurochem Res (2009) 34:1167–1182
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chromatography (TLC), GM1 by slot-blot using cholera
toxin subunit B linked to a peroxidase (Sigma) and phos-
pholipids were determined using the Phospholipid B kit
(WAKO) according to the manufacture’s protocol. Sterols
were isolated and analyzed by gas-chromatography/mass
spectrometry as described [34]. In addition, total sterols
were measured using the Amplex Red Cholesterol Kit
(Invitrogen/Molecular Probes) according to the manufac-
turer’s protocol. In brief, the vacuum dried chloroform
phase was resuspended in DMSO and applied to the assay
in a final dilution of 1:100. The plate was read in a fluo-
rescent micro plate reader using 560 nm wavelengths for
excitation and 590 nm for emission with a 590 nm cutoff.
a- and b-Secretase Activity Assays
Secretase activities were measured using a- and b-secretase
activity Kits (R&D systems) as described [35]. In brief,
half brains of DHCR24-/- and wt mice (n = 4–5 per
group) were homogenized in cell extraction buffer to a final
concentration of 1–2 mg/ml. Homogenates were incubated
on ice for 10 min and centrifuged at 10,000g for 1 min.
Diluted supernatant, reaction buffer and substrates were
added to each well, gently mixed and incubated in the dark
at 37C for 1 h. The plate was read in a fluorescent micro
plate reader using 355 nm wavelengths for excitation and
510 nm for emission with a 495 nm cutoff.
Reconstitution of BACE in Proteoliposomes
and Proteoliposome Activity Assays
Recombinant BACE was purified from insect cells and
reconstituted in large unilamellar vesicles as described
previously [36]. The amount of incorporated BACE was
determined by densitometry of silver-stained SDS–PAGE
gels using a standard curve obtained by loading known
amounts of purified BACE in the range of *10–100 ng per
lane. Consequently, the specific activity of BACE in each
proteoliposome preparation was determined in 0.1 M
NaOAc, pH 4.8 from the slope of the initial linear stage of
the enzyme progression curves measured in a time-
resolved fluorescence assay (excitation 355 nm, emission
385 nm, measured in 20 s intervals for 4,000 s at 37C)
using the FS-1 substrate (Bachem).
Statistical Analyses
Data were statistically analyzed by a two-tailed t-test, with
results deemed significant when P \ 0.05. Statistical
analyses were not performed in case more than 25% of the
DHCR24-/- data points were below detection level. In all
graphs, mean ± SEM (standard error of the mean) are
shown if not otherwise indicated.
Results
Viability and Neuropathological Status of DHCR24-/-
Mice
DHCR24 knock-out mice (DHCR24-/-) were born at
lower frequencies than expected, and were smaller in size
[9]. The frequency of born DHCR24-/- mice from het-
erozygous matings was increased to an almost normal rate
by backcrossing DHCR24?/- mice to a pure FVB back-
ground. To ensure survival of the DHCR24-/- mice, the
number of pups was decreased to 3–4 per mating. Under
these conditions maternal care was ensured; mice were able
to feed (full stomach), and developed normally, although
with poorer growth characteristics. Neuropathological
examinations of Hematoxylin/Eosin- and Luxol Blue-
stained cortical sections revealed no obvious abnormalities
compared to wt littermates. Since DHCR24/seladin-1 is
known to play a role in anti-apoptotic signaling [37–39],
we determined apoptotic events in brains of DHCR24-/-
and wt mice. TUNEL and cleaved caspase-3 stainings did
not reveal any difference between brains of DHCR24-/-
mice when compared to wt brains (not shown).
Brain Sterol and Lipid Distribution in DHCR24-/-
Mice
To determine the effects of DHCR24 deficiency on brain
sterol metabolism (see Suppl. Fig. 1), we analyzed brains of
3- and 16-week-old DHCR24-/- and wt mice using gas-
chromatography/mass-spectrometry [34]. Cholesterol, the
final product of the Kandutsch–Russel pathway, was virtu-
ally absent in DHCR24-/- brains of both ages. Because
desmosterol is the last sterol of the Bloch-pathway and
its reduction is solely catalyzed by DHCR24, this sterol was
greatly accumulating in brains of DHCR24-/- mice
(Fig. 1a). Quantitatively, desmosterol levels in 3-week-old
DHCR24-/- mice reached about 50% of the levels of cho-
lesterol in wt mouse brains, while further desmosterol build-
up in brains of 16-week-old DHCR24-/- mice resulted in
desmosterol concentration comparable to that of cholesterol
in aged-matched wt mice (Fig. 1a, Table 1). Detailed anal-
ysis of brain sterol synthesis revealed that besides
cholesterol, components of the Kandutsch–Russel pathway
such as lathosterol were virtually absent in DHCR24-/-
mice of either age-group. In addition, the brain specific
catabolic product of cholesterol, 24S-hydroxycholesterol
(24S-OH-chol), was significantly reduced with DHCR24
deficiency (Table 1). The total amount of sterols in 3-week-
old DHCR24-/- brains was reduced by *47%, while no
significant difference in total sterols was detected in 16-
week-old DHCR24-/- brains, due to the age-dependent
accumulation of desmosterol. The amount of brain
Neurochem Res (2009) 34:1167–1182 1171
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phospholipids was unchanged between the DHCR24-/- and
wt brains of either age-group (Fig. 1b).
Given the fundamental role of cholesterol in DRM
composition [7, 25], we studied the effects of chronic
cholesterol deficiency on DRM protein and lipid compo-
sition in vivo by preparing DRMs from 3- to 16-week-old
DHCR24-/- and wt brains. Sterol analysis revealed a
major reduction of total sterols in soluble fractions 8–10
of 3-week-old DHCR24-/- brains (47.8 ± 14.3%, P =
0.0091, Fig. 1c), and sterols were even below detection
level in DRM fractions (4–6) of these mice. In contrast to
the 3-week-old mice, sterol levels in soluble fractions 8–10
of 16-week-old DHCR24-/- mice were comparable to that
of aged-matched wt mice, and a substantial amount of
sterols was detected in DRM fractions of 16-week-old
DHCR24-/- mice (83.2 ± 6.2% of wt, Fig. 1c), revealing
a recruitment of desmosterol to DRM fractions of 16-week-
old DHCR24-/- mice.
Determination of the total amount of proteins in soluble
and DRM fractions of 3- and 16-week-old DHCR24-/-
mice revealed that in 3-week-old DHCR24-/- mice
proteins were significantly reduced in DRM fractions
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Fig. 1 Sterol, lipid and protein distribution in brains of 3- and 16-
week-old DHCR24-/- mice. a Brain sterols were determined by GS/
MS. Cholesterol was virtually absent in brains of 3-week-old
DHCR24-/- mice (3 weeks -/-), while desmosterol accumulated
and accounted for *50% of cholesterol compared to wt controls
(3 weeks ?/?, set as 100%). Brains of 16-week-old DHCR24-/-
mice were essentially cholesterol-free (16 weeks -/-), whereas
desmosterol accumulated to levels that are comparable to those of
cholesterol in aged-matched wt controls (16 weeks ?/?). b Phospho-
lipid concentrations in total brain extracts were similar in both
genotypes and age-groups. c Soluble fractions were separated from
insoluble DRM fractions by sucrose gradient fractionation. Total
sterols were substantially reduced in soluble factions of 3-week-old
DHCR24-/- mice compared to the corresponding values of their wt
littermates (set as 100%), while sterols were below detection level in
DRM fractions of these mice (n.d., not detectable). Sterol levels were
similar in soluble fractions of 16-week-old DHCR24-/- and wt mice,
and the amount of desmosterol recruited to DRM fractions of 16-
week-old DHCR24-/- mice was not different from the values of
aged-matched controls (set as 100%). d The amount of total proteins
was increased in soluble and decreased in DRM fractions of 3-week-
old DHCR24-/- mice, indicating a replacement of raft proteins to
non-raft fractions. This replacement was abolished in 16-week-old
DHCR24-/- mice when compared to aged-matched control (set as
100%) (* P \ 0.04, ** P \ 0.01, *** P \ 0.001)
Table 1 Brain sterol concentrations
Age Cholesterol (lg/mg) Desmosterol (lg/mg) Lathosterol (ng/mg) 24S-OH-Chol (ng/mg)
3 Weeks ?/? 60 ± 7 0.6 ± 0.08 391 ± 87 340 ± 53
-/- 2.5 ± 0.05* 27 ± 0.05* 25 ± 1* 15 ± 7*
16 Weeks ?/? 88 ± 7 0.5 ± 0.02 140 ± 14 157 ± 7.4
-/- 3 ± 0.3* 97 ± 11* 1 ± 0.4* 10 ± 2*
Concentrations of cholesterol and desmosterol (in lg/mg wet weight; mean ± SD), and lathosterol and 24S-OH-cholesterol (in ng/mg wet
weight; mean ± SD) in brains of wt (?/?) and DHCR24-/- (-/-) mice of either age-group. Sterols were measured by GC/MS
* P \ 0.05 versus aged-matched controls
1172 Neurochem Res (2009) 34:1167–1182
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(15.3 ± 8.7% of wt, P = 0.0044, Fig. 1d), while no
significant difference was detected in DRM fractions of
16-week-old DHCR24-/- mice, when compared to aged-
matched wt control levels. Unlike the amount of sterols, the
detected amount of proteins in soluble fractions of 3-week-
old DHCR24-/- mice was higher (130 ± 8.6%, P = 0.04)
compared to aged matched wt mice, possibly indicating a
displacement of proteins from DRM to soluble fractions in
3-week-old DHCR24-/- mice. This displacement was
abolished in 16-week-old DHCR24-/- mice, where the
amount of proteins detected in soluble fractions was similar
to that of aged-matched wt mice (Fig. 1d).
Subcellular Protein and Lipid Distribution in Brains
of DHCR24-/- Mice
Analysis of the flotation profiles of the raft-specific protein
Prpc (cellular prion protein) revealed a substantial per-
centage of this protein in DRM fractions of 3-week-old wt
brains (47.6 ± 4.6%), while dramatically less Prpc was
detected in these fractions of 3-week-old DHCR24-/-
brains (3.5 ± 1.2%, Fig. 2a). Altered DRM formation in
3-week-old DHCR24-/- brains was further confirmed
determining the subcellular distribution of the raft marker
flotillin-1 that was virtually absent from DRM fraction of
3-week-old.
DHCR24-/- brains, while 42.8 ± 3.9% of flotillin-1
was present in these fractions of wt mice (Fig. 2b). In
addition, the b-secretase BACE that is known to reside
within lipid rafts, was substantially reduced in DRM frac-
tions of 3-week-old DHCR24-/- brains (3.7 ± 1.6%),
while an evident percentage of BACE was detected in these
fractions of aged-matched wt mice (43.7 ± 0.4%, Fig. 2c).
However, the absolute levels of Prpc, flotillin-1 and BACE
were not altered in total brain homogenates of 3-week-old
DHCR24-/- and wt mice (see Suppl. Fig. 2c). The non-raft
protein APP remained in the heavy fractions to a compa-
rable extent in brains of 3-week-old DHCR24-/- and wt
mice (Fig. 2d). Lipid analysis of sucrose gradient fractions
of 3-week-old DHCR24-/- mice revealed major changes in
the distribution of SM and the ganglioside GM1 in the
DHCR24-/- compared to wt brains (Suppl. Fig. 2a, b).
While in control brains 37.6 ± 6.5% of SM and
71.8 ± 5.5% of GM1 were found in DRM fractions 4–6,
only 6 ± 3.0% of SM and 2.4 ± 1.2% of GM1 were
present in DRM fractions of DHCR24-/- brains (Suppl.
Fig. 2a, b).
In contrast, no significant differences in the subcellular
distribution of raft-proteins were detected between 16-week-
old DHCR24-/- and wt mice: distinct proportions of Prpc
(45.8 ± 2.1%, Fig. 3a), flotillin-1 (48.1 ± 2.1%, Fig. 3b)
and BACE (44.6 ± 6.6%, Fig. 3c) were detected in DRM
fractions of 16-week-old DHCR24-/- brains, comparable to
those in DRM fractions of wt brains (48.1 ± 1.7 and
42.8 ± 7.3 and 36 ± 1.1%, respectively, Fig. 3a–c). Like in
3-week-old DHCR24-/- mice, the subcellular distribution
of the mainly non-raft protein APP in soluble fractions was
not altered between the two genotypes in the 16-week-old
brains (Fig. 3d).
Plasminogen Binding and Plasmin Activity
in DHCR24-/- Mice
To evaluate the functional consequences of the observed
disturbances in DRM composition in 3-week-old
DHCR24-/- mice, we analyzed plasmin activity in plasma
membranes of 3- and 16-week-old DHCR24-/- mouse
brains. Plasmin activity is regulated by plasminogen
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Fig. 2 Effects of sterol alterations on membrane organization of
3-week-old DHCR24-/- mice. Total extracts from 3-week-old mouse
brains were separated in a sucrose gradient. Fractions were collected
and numbered from the lightest to the heaviest (2–10). Representative
Western blots of the flotation profiles of the raft proteins Prpc (a),
flotillin-1 (b) and BACE (c) show a general displacement of these
proteins from DRM to soluble fractions of 3-week-old DHCR24-/-
mice (3 weeks -/-), when compared to wt controls (3 weeks ?/?),
while the cellular distribution of APP (d), a non-raft protein, was not
altered between the two genotypes. Graphs on the right show the
distribution of the four proteins in soluble (8–10) and DRM (4–6)
fractions as average percentage of the total amount of the respective
proteins along the entire gradient
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activators, plasminogen activator inhibitors and plasmin
inhibitors [40]. In addition, plasmin generation is depen-
dent on the binding of plasminogen to the plasma
membrane [41]. Experimental data point to DRMs as the
sites where the plasminogen binding and activation take
place. Moreover, plasminogen-binding molecules are
enriched in rafts of neurons [42], and plasmin is almost
exclusively present in these neuronal microdomains [43].
We measured plasmin enzymatic activity using the chro-
mogenic substrate S-2251 specific for this protease.
Plasmin activity in isolated membranes of 3-week-old
DHCR24-/- brains was dramatically reduced (Fig. 4a).
Accordingly, the amount of endogenous plasminogen
bound to the membrane was diminished in 3-week-old
DHCR24-/- mice, while the endogenous levels of total
plasminogen were similar to that in aged-matched wt mice
(Fig. 4b), suggesting an impaired binding capacity for
plasminogen to the membrane. Conversely, plasmin
activity was restored in brains of 16-week-old DHCR24-/-
mice (Fig. 4c) and no difference was detected in the
amount of membrane-bound plasminogen between
16-week-old DHCR24-/- and aged-matched wt mice
(Fig. 4d).
APP Processing and Ab Generation in DHCR24-/-
Mice
Next, we studied APP processing as another example of
membrane-dependent proteolysis and raft-related cellular
event to evaluate the effects of chronic cholesterol defi-
ciency and possible replacement by desmosterol on
functional level in vivo. In 3- and 16-week-old mice, levels
of cellular full-length APP were similar in brains of
DHCR24-/- and wt mice, and there was no significant
alteration in membrane fractions of full-length APP
(Fig. 5a, b). Analysis of APP cleavage products revealed
that the amount of a-CTF was not significantly different in
the 3-week-old DHCR24-/- brains (124 ± 9.8%, Fig. 5a, c),
whereas the b-CTF was significantly lower (54 ± 5.6%,
P = 0.009, Fig. 5a, c), when compared to wt mice. How-
ever, this difference was abolished in brains of 16-week-old
DHCR24-/- mice, which exhibited similar levels of b-CTF
when compared to aged-matched wt mice (Fig. 5b, c). In
addition, Ab40 levels were significantly lower in brains of
3-week-old DHCR24-/- mice (42.9 ± 4.3%, P = 0.0004,
Fig. 5d). Brain Ab42 levels were below detection limits in
either genotype in 3-week-old mice. On the contrary,
Ab40 concentrations were similar between 16-week-old
DHCR24-/- and wt mice (Fig. 5d). Moreover, in 16-week-
old mice, Ab42 was detectable in either genotype, and did
not differ between DHCR24-/- and wt mice (Fig. 5d).
These data provide the evidence that APP processing
and Ab generation are strongly influenced by cholesterol
deficiency due to DHCR24 disruption in vivo, whereas
high levels of desmosterol in 16-week-old DHCR24-/-
mice seem to rescue these deficits. To evaluate whether the
changes in APP processing and Ab generation in 3-week-
old DHCR24-/- brains were due to altered activities of
involved secretases, we determined a- , b- and c-secretase
activity in brain homogenates of DHCR24-/- and wt mice.
b-secretase activity was significant reduced in 3-week-old
DHCR24-/- brains (71.4 ± 2.4%, P = 0.0257, Fig. 5e).
In addition there was a moderate reduction in c-secretase
activity in brains of 3-week-old DHCR24-/- mice
(90.2 ± 5%, P = 0.039, Fig. 5e). Brain activity levels of
a-secretase were unchanged in 3-week-old DHCR24-/-
mice when compared to age-matched wt controls. In con-
trast, brain activities of all three secretases were unchanged
in 16-week-old DHCR24-/- mice, suggesting that high
concentrations of desmosterol and integration of desmos-
terol in the membrane restores full b-and c-secretase
activity.
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Fig. 3 Effects of sterol alterations on membrane organization of 16-
week-old DHCR24-/- mice. Total extracts from 16-week-old mouse
brains were separated in a sucrose gradient. Fractions were collected
and numbered from the lightest to the heaviest (2–10). Compared to
3-week-old DHCR24-/- mice, raft-protein levels in DRM fractions of
16-week-old DHCR24-/- mice (16 weeks -/-) were restored to wt
(16 weeks ?/?) level. Distinct proportions of Prpc (a), flotillin-1 (b)
and BACE (c) were determined in DRM fractions of 16-week-old
DHCR24-/- mice. d APP distribution was similar in 16-week-old
DHCR24-/- and wt mice. Graphs on the right show the distribution
of the four proteins in soluble (8–10) and DRM (4–6) fractions as
average percentage of the total amount of the respective proteins
along the entire gradient
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To more precisely examine the effects of DHCR24
deficiency, cholesterol paucity and desmosterol accumu-
lation on APP ectodomain shedding and Ab generation we
prepared primary cortical neurons of wt and DHCR24-/-
mice, cultivated for time periods of 4 to 8–10 days in vitro
(div) in serum- and cholesterol-free medium comple-
mented with B27. There were no differences in cell
morphology and viability between wt and DHCR24-/-
neurons as determined by Map2 staining (data not shown)
and the in vitro toxicology assays based on lactate-dehy-
drogenase (LDH) (Fig. 6a). Sterol analyses of neuronal
cultures of DHCR24-/- mice revealed gradually increasing
sterol levels with cultivation time (Fig. 6b), indicating that
desmosterol concentrations rise over time, just as it was
observed in knock-out mice. Desmosterol levels in primary
neurons of DHCR24-/- mice after 4 div were significantly
reduced (56 ± 5.6%, P = 0.0013, Fig. 6c) compared to
cholesterol levels in wt neurons, while after 8–10 div both
values were similar (Fig. 6d).
Measurements of Ab peptides by murine Ab ELISA
showed significantly lower levels of Ab40 (58.7 ± 21.1%,
P = 0.002) and Ab42 (57.4 ± 15.9%, P = 0.001) in
DHCR24-/- neurons cultured for 4 div compared to control
cultures (Fig. 6e), while both Ab species were present to
comparable levels in neurons of both genotypes cultured for
8–10 div (Fig. 6f). These data clearly indicate that desmos-
terol, insofar it is abundant enough, can rescue the membrane-
related deficits caused by chronic cholesterol deficiency.
Specific Activity of BACE Reconstituted
in Proteoliposomes
To rule out that factors other than high desmosterol con-
centration are responsible for the observed rescue effects in
APP processing, we investigated the specific activity of
BACE reconstituted in large unilammelar vesicles formu-
lated as sterol free, or including cholesterol, desmosterol,
or 7-ketocholesterol.
BACE was reconstituted in vesicles composed of
palmitoyloleoyl phosphatidylcholine (POPC), brain phos-
phatidylethanolamine (PE), and brain SM in a ratio of
50:20:30 mol/mol (approximately the same ratios in w/w)
without a sterol component, and in vesicles containing
POPC:brainPE:brainSM:cholesterol in a ratio of 50:20:10:
20 mol/mol (*56:22:11:11 w/w), POPC:brainPE:brainSM:
desmosterol 50:20:10:20 mol/mol (*56:22:11:11 w/w) and
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Fig. 4 Plasmin activity and membrane plasminogen binding in
DHCR24-/- mice. a Plasmin activity (expressed in arbitrary units,
a.u.) was measured at the indicated times in membranes isolated from
wild-type (?/?) and DHCR24-/- (-/-) mouse brains using the
specific chromogenic substrate S-2251. Plasmin activity was clearly
reduced in membrane fractions prepared from 3-week-old
DHCR24-/- mouse brains (3 weeks -/-) compared to wt controls
(3 weeks ?/?). b Membrane-bound fractions of plasminogen (mem.
plasminogen) were virtually absent from extracts of 3-week-old
DHCR24-/- brains, while levels of total cellular plasminogen (tot.
plasminogen) were not altered between 3-week-old DHCR24-/- and
wt brains. c In 16-week-old DHCR24-/- mice (16 weeks -/-),
plasmin activity was restored to wt levels (16 weeks ?/?). d
Plasminogen levels bound to membranes of 16-week-old DHCR24-/-
mice were comparable to aged-matched wt mice and no difference
was observed in total plasminogen levels between the two genotypes.
GAPDH is shown as a loading control for total extracts, b-actin for
the membrane preparations
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POPC:brainPE:brainSM:7-ketocholesterol 50:20:10:20 mol/
mol (*56:22:11:11 w/w).
Relative to cholesterol containing vesicles in which
BACE activity was set as 100%, sterol-free proteoliposomes
displayed a specific activity of only 48 ± 2.8%. However,
desmosterol caused an effect comparable to cholesterol,
increasing the specific activity of BACE to 80 ± 10.4%
(Fig. 7a).
In order to rule out that the increased activity primarily
depends on decreasing amounts of SM rather than on the
identity of the included sterol, BACE was reconstituted in
vesicles with 7-ketocholesterol. This sterol was studied in
model membranes and was found to differ from cholesterol
in a number of important parameters, for example,
7-ketocholesterol is less effective in forming ordered lipid
domains, and was shown to differentially modulate mem-
brane properties involved in protein-membrane association
and function [44]. Compared to cholesterol-free proteo-
liposomes, only a minor effect was observed with
7-ketocholesterol (56 ± 5.8%, Fig. 7a). Figure 7b shows
the range of linear correlation between BACE activity and
the slope of the initial stage of progression curve.
Binding and Internalization of GM1 in DHCR24-/-
Derived Primary Cortical Neurons
Our studies of APP processing and Ab generation, and of
BACE activity in desmosterol-containing proteoliposomes
suggest that desmosterol can functionally replace choles-
terol in DHCR24-/- mice. To investigate using intact live
cells the functional replacement by desmosterol of cho-
lesterol, we monitored the plasma membrane distribution
and the internalization of the raft-associated lipid GM1 in
primary cortical neurons of wt and DHCR24-/- mice.
GM1 is a glycosylated sphingolipid enriched in membrane
microdomains and in membranes within caveole. Biosyn-
thesis, endocytosis and membrane trafficking of GM1 are
highly sensitive to acute cholesterol depletion [45]. The
bacterial toxin subunit b from vibrio cholera (Cholera
toxin b) binds GM1 with high specificity [46]. When
fluorescently modified with FITC (FITC-Ctxb), it is rou-
tinely employed either as a stain to visualize the subcellular
localization of GM1, or as an extracellular ligand to visu-
alize GM1 endocytosis events and vesicular trafficking
[45]. We visualized primary cortical neurons derived from
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Fig. 5 APP processing, Ab generation and secretase activity in brains
of DHCR24-/- mice. Hemi brains of mice were homogenized in a
Tris-buffer containing 2% SDS (total extracts) or in a MES buffer
lacking detergent (for membrane preparations). Total extracts
and membrane fractions were subjected to Western blot analysis.
a Cellular and membrane (mem.) level of full length (FL) APP were
unchanged between the two genotypes, whereas the levels of CTFs
were altered in 3-week-old DHCR24-/- (3 weeks -/-) mouse brains.
b In 16-week-old DHCR24-/- mice (16 weeks -/-) cellular and
membrane FL APP and CTF levels were not different from wt
controls (16 weeks ?/?). GAPDH was used as internal loading
control for total extracts. c Quantification of the CTFs revealed that
a-CTFs were not altered in DHCR24-/- mice of either age-group,
whereas b-CTFs were significantly reduced in 3-week-old
DHCR24-/- brains, when compared to corresponding levels of age-
matched wt mice (3 weeks ?/?, set as 100%), while this reduction
was abolished in 16-week-old DHCR24-/- brains. d Hemi brains
were homogenized in PBS and subjected to murine Ab ELISA
analyses as described in ‘‘Materials and methods’’. In comparison to
age-matched controls (set as 100%), Ab40 levels were significantly
diminished in 3-week-old DHCR24-/- brains, while these levels were
normal in 16-week-old mice. Ab42 peptides were below detection
level in brains of 3-week-old DHCR24-/- and wt mice (n.d., not
detectable). In 16-week-old mice Ab42 levels were unchanged
compared to aged-matched controls. e Hemi brains were homogenized
and subjected to secretase activity assays. Proteolytic activity of
a-secretase was unchanged in DHCR24-/- brains of either age-group.
b- and c-secretase activity were significantly reduced in 3-week-old
DHCR24-/- brains, while full proteolytic activity of both secretases
was observed in 16-week-old DHCR24-/- mice compared to their
age-matched controls. Activity levels of secretases in aged-matched
wt controls were set as 100% (* P \ 0.04, ** P \ 0.01,
*** P \ 0.0005)
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Fig. 7 Specific activity of BACE reconstituted in proteoliposomes.
a BACE was reconstituted in vesicles composed of POPC:brain-
PE:brainSM 50:20:30 mol/mol, POPC:brainPE:brainSM:cholesterol
50:20:10:20 mol/mol, POPC:brainPE:brainSM:desmosterol 50:20:10:
20 mol/mol and POPC:brainPE:brainSM:7-ketocholesterol 50:20:10:
20 mol/mol. The specific activity of BACE in each proteoliposome
preparation was determined from the slope of the initial linear stage
of the enzyme progression curves measured in a time-resolved
fluorescence assay. Specific BACE activity in each particular mixture
is expressed in percentage relative to the specific activity of BACE in
cholesterol containing proteoliposomes. Incorporation of desmosterol
caused an effect comparable to that of cholesterol, markedly increasing
the specific activity of BACE, while incorporation of 7-ketocholesterol,
a membrane inactive sterol, showed only a minor effect. b Range of
linear correlation between BACE activity and the slope (in arbitrary
units, a.u.) of the initial stage of progression curve
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Fig. 6 Sterol distribution and Ab generation in primary neurons of
DHCR24-/- mice. Primary neurons were prepared from DHCR24-/-
and wt mice and cultured in cholesterol- and serum-free medium.
a Cell viability of primary neurons in culture for up to 10 days in vitro
(div) was not different between DHCR24-/- (4/8–10 div -/-) and wt
(4/8–10 div ?/?) neurons. b Sterol levels of primary neurons derived
from DHCR24-/- mice gradually increased with age reaching wt
levels (set as 100%) between 8 and 10 div. c After 4 div, the levels of
desmosterol in DHCR24-/- neurons were approximately half of that
of cholesterol in wt controls (set as 100%). d After 8–10 div,
desmosterol concentrations in neurons prepared from DHCR24-/-
mice were similar to that of cholesterol in wt control cultures (set as
100%). e Secreted Ab40 and Ab42 in the supernatant of the
DHCR24-/- cultures revealed a significant reduction of both peptides
compared to control cultures (set as 100%) after 4–5 div. f The
difference in Ab40 and Ab42 levels between DHCR24
-/- and wt
neurons (set as 100%) detected in 4–5 div-cultures was abolished
after 8–10 div (** P \ 0.003)
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DHCR24-/- mice after 6 div when desmosterol levels are
comparable to the cholesterol levels in neurons derived
from wt mice. Confocal micrographs of live primary
cortical neurons of wt and DHCR24-/- mice show a
comparable plasma membrane staining of FITC-Ctxb
(Fig. 8a, b), when they are pulsed for 2 min with culture
media containing the ligand, and then immediately visu-
alized. This indicates that the surface accessible pools of
plasma membrane-exposed GM1 are similar. Next, we
visualized the internalization of plasma membrane bound
FITC-Ctxb in live neurons. To distinguish the intracellular
FITC-Ctxb from that which is cell surface-associated, we
took advantage of the acid sensitivity of FITC. Following a
2 min pulse with culture media containing the ligand and
30 min chase in which cells were cultured without ligand,
live cells were bathed in low-pH media to ‘‘quench’’ the
fluorescent signal of extracellular dye. Micrographs
acquired within the first 5–10 min of exposure to low-pH
media reveal that the intracellular fraction of FITC-Ctxb in
live neurons derived of wt and DHCR24-/- mice are
similar (Fig. 8c, d).
These data indicate that the steady state distribution and
the internalization of plasma membrane GM1 are compa-
rable when the membrane sterol desmosterol replaces
Fig. 8 Binding and internalization of GM1 in live DHCR24-/-
derived primary cortical neurons. Confocal micrographs of live (a) wt
and (b) DHCR24-/- derived primary cortical neurons pulsed for
2 min with FITC-Ctxb are shown, including four panels for each:
FITC CTx overview image, FITC CTx inset 1, FITC CTx inset 2,
Transmitted Light. The FITC-Ctxb shows a pattern similar to the
neuron plasma membrane pattern (compare FITC CTx and transmit-
ted light), indicating FITC-Ctxb is plasma membrane associated in wt
and DHCR24-/- live neurons at 6 div. The pool of receptor GM1 is
similar in wt and DHCR24-/- live neurons at 6 div since fluorescence
intensity of FITC-Ctxb is comparable (compare FITC CTx intensity
of a–b). c Wt and d DHCR24-/- derived primary cortical neuron
micrographs of intracellular FITC-Ctxb selectively visualized in live
cells using low pH media to shift the fluorescence spectrum of FITC.
Images acquired at low pH show the FITC-Ctxb is internalized
(compare FITC CTx and transmitted light; compare FITC Ctx of
a and b to c and d). Levels of internalized GM1 are comparable
(compare FITC CTx intensity of c–d). Scale bar is 10 microns of
FITC CTx overview image, insets are 94 magnification of FITC CTx
overview
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cholesterol. In summary, our data suggest that desmosterol
functionally replaces cholesterol in DHCR24-/- mice.
Discussion
The results of this study show that desmosterol—when it is
present in the DHCR24-/- mouse brain as abundantly as
naturally occurring cholesterol—replaced cholesterol in
DRMs and restored membrane-related functions including
membrane receptor ligand binding and activation, and
regulation of membrane protein proteolytic activity.
In DHCR24-/- mice, the conversion of desmosterol to
cholesterol is abolished, causing an accumulation of des-
mosterol with age over time. Whereas in 3-week-old
DHCR24-/- mice brain desmosterol concentrations were
only half of the cholesterol content in wt brains, desmosterol
accumulated in 16-week-old DHCR24-/- mouse brains to a
concentration similar to that of cholesterol in control brains.
A possible explanation for the decelerated production and
accumulation of desmosterol in 3-week-old DHCR24-/-
mouse brains compared to cholesterol in control brains
might be an inhibiting effect of accumulating sterol inter-
mediates of the Bloch-pathway on the HMG-coA-reductase
[47–49], a rate-limiting enzyme in the cholesterol biosyn-
thesis pathway. This inhibiting effect is likely to be
narrowed in adulthood when brain cholesterol synthesis is
quite low compared to developmental stages [8].
Brain cholesterol deficiency and low abundance of
desmosterol in 3-week-old DHCR24-/- mice were asso-
ciated with major changes in distribution of raft proteins
and altered lipid composition of DRMs, challenging the
very existence of lipid rafts in these mice. In contrast, high
levels of desmosterol in 16-week-old DHCR24-/- mice
allowed desmosterol-DRM formation and protein recruit-
ment of raft marker in these domains, strongly suggesting
that, at equimolar concentrations, desmosterol can replace
cholesterol resulting in normal membrane integrity and
proper DRM organization.
Our data show that extensive cholesterol depletion in
3-week-old DHCR24-/- brains led to lower b-cleavage and
diminished Ab production. The reduced activity of BACE
and the c-secretase complex suggest that defective mem-
brane composition in brains of 3-week-old DHCR24-/-
mice insufficiently maintained enzymatic activity of the two
secretases, which is likely to contribute to the observed
changes in Ab generation in these mice. This interpretation
is in line with several previous findings showing that dis-
rupted cholesterol transport can alter subcelluar distribution
of presenilin and change APP processing [35, 50], and that
depletion of membrane cholesterol results in complete
inhibition of c-secretase cleavage of APP [51]. Moreover, it
was shown that alterations in b-secretase activity might be
responsible for the dependence of Ab production on cho-
lesterol levels. Crosslinking experiments of APP and BACE
in raft domains [21] and targeting of BACE to rafts [22]
remarkably affect Ab production in a cholesterol dependent-
manner. In 16-week-old DHCR24-/- mice, full b- and
c-secretase activity was observed, indicating that desmos-
terol membrane repartition in place of cholesterol allows
normal BACE and gamma-secretase complex functioning.
It has been previously shown that cholesterol content
correlates with BACE activity in proteoliposomes. Specific
activity of BACE increased twofold in vesicles containing
15% w/w cholesterol relative to cholesterol-free vesicles
[36]. The effect of desmosterol was investigated in a
similar system. Desmosterol was found to be effective in
supporting BACE activity in this reconstituted system to an
extent similar to cholesterol, while the effect of 7-keto-
cholesterol was much weaker. These data support the
concept in which cholesterol and its closely related deriv-
atives that exhibit similar physico-chemical properties in
lipid mixtures relevant to physiological membranes play an
important role in supporting BACE activity and hence Ab
formation.
Inborn errors of cholesterol synthesis cause human
malformation syndromes [52]. It is still a matter of debate,
whether the malformations result from lacking cholesterol
concentrations during development or from the buildup of
the respective precursor. Therefore, the effect of choles-
terol loss and its substitution by various precursors was
investigated intensively during the last years either using
model membranes [17, 18, 49, 53, 54], employing bio-
logical membranes treated with cholesterol extracting
agents and/or sterol intermediates [55, 56] or applying
inhibitors targeting specific reductases in the cholesterol
biosynthesis pathway [19, 57–59]. DHCR24-knock-outs
are the first viable cholesterol-free mice. Their mild phe-
notype, being small and infertile, is in marked contrast to
the severe inborn defects of human desmosterolosis
patients who display an insufficient cholesterol reductase
activity due to mutations in the dhcr24 gene [6, 60]. This
marked difference might be explained by the availability of
maternal cholesterol during mouse embryonic development
[9, 61]. However, desmosterol accumulation per se does
not seem to cause adverse health effects [56].
In model membranes, the influence of desmosterol on
lipid order was shown to be similar to that of cholesterol
and both sterols seem to affect lipid packing to a compa-
rable extent [17]. On a functional level, desmosterol was
shown to activate LXR-targeted genes in vitro [49] and in
vivo [61] and to substitute for cholesterol in the developing
and neonatal rat retina [58]. However, it was shown that
desmosterol in model membranes promotes the formation
and stability of ordered domains somewhat less efficiently
than cholesterol [53, 55], and recent data show that
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inhibition of 24-dehydrocholesterol reductase in HeLa cells
increases the structural heterogeneity of caveolae due to a
decreased affinity of caveolin-1 for sterol and a reduced
stability of caveolin oligomers [19]. Nevertheless, substi-
tution of cholesterol by desmosterol does not affect
membrane integrity or caveolar invagination and caveolar
ligand uptake is only moderately inhibited in these cells
[19]. Vainio et al. [55] found that in mammalian cell mem-
branes desmosterol associated less avidly than cholesterol
with DRMs. Their model is different from ours in that they
use CHO cells containing high amounts of endogenous
desmosterol concentrations, but normal levels of cholesterol,
therefore the presence of cholesterol is likely to affect des-
mosterol-DRM association. Despite this difference, our
results are consistent with the idea that desmosterol is
capable to associate with DRMs. Furthermore, Vainio et al.
also showed that exchanging of *70% of cholesterol by
desmosterol in mammalian cell membranes using methyl-
b-cyclodextrin impaired raft-dependent signaling via the
insulin receptor, whereas protein secretion, a process highly
dependent on membrane composition and properties [62],
was not affected by cholesterol substitution with des-
mosterol. These findings suggest that short-term, methyl-
b-cyclodextrin-mediated cholesterol replacement in mem-
branes may influence certain raft-dependent functions while
others remain unaffected. Using a cellular model in which
endogenous desmosterol replaces cholesterol, reaching a
steady state, we show that APP processing and Ab generation
are not affected, and the distribution and the internalization
of plasma membrane GM1 are comparable to cholesterol
containing membranes. Moreover, we found no significant
differences in membrane receptor ligand binding and acti-
vation, and regulation of membrane protein proteolytic
activity between 16-week-old DHCR24-/- and wt mice,
confirming the functional activity of endogenous desmos-
terol containing membranes in 16-week-old DHCR24-/-
brains.
In conclusion, our data support the concept that proper
raft organization is required to maintain physiological APP
processing and Ab generation, and they show that des-
mosterol is capable of substituting for cholesterol and
taking over its role in membrane structure, raft-formation
and membrane-related processes in vivo.
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